ReviewAsia Pacific allergy2021
Gyeonggi-do Atopy · Asthma Education Information Center in Korea: a key partner in the Korean Asthma Allergy Program.
Review in Asia Pacific allergy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gyeonggi-do Atopy · Asthma Education Information Center in Korea: a key partner in the Korean Asthma Allergy Program.Asia Pacific allergy · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis are common and cause high socioeconomic burden. Allergic disease is a matter of not just for a patient, but also for a family and the society. The Korean government, the Korean Disease Control and Prevention Agency, started the nationwide asthma and atopic disease prevention and management plan in collaborations with the opinion leaders from the Korean Academy of Asthma, Allergy, and Clinical Immunology, and the Korea Asthma Allergy Foundation since 2007. Seoul Atopy · Asthma Education Information Center was established in 2008 by the Korean Disease Control and Prevention Agency and the Seoul metropolitan government to provide the reliable and accurate information on asthma and allergic diseases. In 2011, Gyeonggi-do Atopy ∙ Asthma Education Information Center was established by the Korean Disease Control and Prevention Agency and the Gyeonggi-do provincial government. The activities of the center are as follows: (1) atopy ∙ asthma-friendly school program, (2) development/distribution of the educational materials, (3) open lectures for the community, patients, their caregivers, older people, nurses, pharmacists, and doctors, (4) collaborations with the Korean Disease Control and Prevention Agency, the Gyeonggi-do provincial government, the office of education, and the public health centers, (5) collaborations with the Gyeonggi-do fire services to educate 119 rescue teams on the allergic emergency conditions, (6) international collaborations. In this article, 10 years of experience and achievement from the Gyeonggi-do Atopy ∙ Asthma Education Information Center were described, especially on the atopy ∙ asthma-friendly school program.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.